Cancer Center Amsterdam
-
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer
Rijnders, M., Nakauma-González, J. A., Robbrecht, D. G. J., Gil-Jimenez, A., Balcioglu, H. E., Oostvogels, A. A. M., Aarts, M. J. B., Boormans, J. L., Hamberg, P., van der Heijden, M. S., Szabados, B. E., van Leenders, G. J. L. H., Mehra, N., Voortman, J., Westgeest, H. M., de Wit, R., van der Veldt, A. A. M., Debets, R. & Lolkema, M. P., 1 Dec 2024, In: Nature communications. 15, 1, 1349.Research output: Contribution to journal › Article › Academic › peer-review
-
The narrow road to expanded access
Post, H. C., Schutte, T., Voortman, J., Bartelink, I. H., van Laarhoven, H. W. M. & Crul, M., Sept 2024, In: Journal of Cancer Policy. 41, p. 100490 100490.Research output: Contribution to journal › Letter › Academic › peer-review
-
No prime time yet for checkpoint inhibitors in localised head and neck squamous cell carcinoma
Voortman, J., May 2024, In: The Lancet Oncology. 25, 5, p. 533-534 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications